Fulgent Genetics (FLGT) Interest & Investment Income (2018 - 2026)

Fulgent Genetics has reported Interest & Investment Income for 9 years, with the latest figure at $6.4 million in Q2 2026.

• Quarterly Interest & Investment Income fell 20.85% year-over-year to $6.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.9 million (down 7.6% YoY) and the FY2025 annual result came in at $30.9 million, down 1.23% from the prior year.
• Interest & Investment Income eased to $6.4 million in Q2 2026 per FLGT's latest filing, from $8.7 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $8.7 million in Q1 2026 and troughed at $45000.0 in Q1 2022.
• A 5-year average of $5.8 million and a median of $6.7 million in 2023 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 9288.57% in 2022, down 84.04% in 2022.
• Over 5 years, Interest & Investment Income stood at $3.2 million in 2022, then soared by 80.66% to $5.8 million in 2023, then soared by 39.81% to $8.1 million in 2024, then fell by 14.61% to $6.9 million in 2025, then declined by 7.67% to $6.4 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $6.4 million, $8.7 million, and $6.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.